This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brecher, P. Articles by Chobanian, A. V. Search for Related Content PubMed PubMed Citation Articles by Brecher, P. Articles by Chobanian, A. V.

Hypertension, Vol 3, 198-204, Copyright © 1981 by American Heart Association

ARTICLES

Properties of angiotensin-converting enzyme in intact cerebral microvessels

P Brecher, A Tercyak and AV Chobanian

Angiotensin-converting enzyme (ACE) was studied in preparations of microvessels isolated from rabbit cerebral cortex. Activity was determined by measuring the degradation of hippuryl-histidyl-leucine (Hip-His-Leu) by the intact microvessels in a physiological salt solution at pH 7.4. ACE activity was dependent on both substrate and chloride ion concentration and was inhibited by captopril in a manner similar to that observed previously with tissue homogenates. Angiotensin I was rapidly degraded by the intact microvessels, even in the presence of 10(-6)M captopril. An advantage of the methodology employed was the ability to pretreat the microvessels and then assess the effect of pretreatment by transfer to a postincubation assay system. Pretreatment with a hyperosmolar urea solution did not change ACE activity or cause release of ACE from the microvessels, although lactic dehydrogenase and lysosomal enzymes were released. Pretreatment with captopril caused a lag in the subsequent degradation of Hip-His- Leu, presumably reflecting dissociation of inhibitor from the cell- associated enzyme. ACE activity was unaffected by hypoxic or anoxic incubation conditions. The ability to measure ACE activity of the microvessels in vitro provides a unique opportunity to study the properties of the enzyme in intact cerebrovascular endothelial cells.

This article has been cited by other articles:

				M. Walters, S. Muir, I. Shah, and K. Lees Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction Stroke, August 1, 2004; 35(8): 1899 - 1902. [Abstract] [Full Text] [PDF]

				T. Ito, Y. Nishimura, and J. Saavedra Pre-treatment with candesartan protects from cerebral ischaemia Journal of Renin-Angiotensin-Aldosterone System, September 1, 2001; 2(3): 174 - 179. [Abstract] [PDF]

				J. M Saavedra, T. Ito, and Y. Nishimura Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S102 - S109. [PDF]

				Y. Nishimura, T. Ito, J. M. Saavedra, and K. Sandberg Angiotensin II AT1 Blockade Normalizes Cerebrovascular Autoregulation and Reduces Cerebral Ischemia in Spontaneously Hypertensive Rats Editorial Comment Stroke, October 1, 2000; 31(10): 2478 - 2486. [Abstract] [Full Text] [PDF]

				A. V. Chobanian, S. Hope, and P. Brecher Dissociation Between the Antiatherosclerotic Effect of Trandolapril and Suppression of Serum and Aortic Angiotensin-Converting Enzyme Activity in the Watanabe Heritable Hyperlipidemic Rabbit Hypertension, June 1, 1995; 25(6): 1306 - 1310. [Abstract] [Full Text]